Response to "Third generation aromatase inhibitors may prevent endometrial growth and reverse tamoxifen-induced uterine changes in postmenopausal breast cancer patients", by L.!Morales et al. (Ann Oncol 2005; 16: 70-74)

被引：1

|

作者：

Cohen, I ^{[1
]}

机构：

[1] Meir Hosp, Sapir Med Ctr, Dept Obstet & Gynecol, Kefar Sava, Israel

来源：

ANNALS OF ONCOLOGY | 2005年 / 16卷 / 08期

关键词：

D O I：

10.1093/annonc/mdi236

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：1402 / 1402

页数：1

相关论文

共 3 条

[1] Third generation aromatase inhibitors may prevent endometrial growth and reverse tamoxifen-induced uterine changes in postmenopausal breast cancer patients
Morales, L
Timmerman, D
Neven, P
Konstantinovic, ML
Carbonez, A
Van Huffel, S
Ameye, L
Weltens, C
Christiaens, MR
Vergote, I
Paridaens, R
[J]. ANNALS OF ONCOLOGY, 2005, 16 (01) : 70 - 74
[2] Reply to the Letter to the Editor on "Third generation aromatase inhibitors may prevent endometrial growth and reverse tamoxifen-induced uterine changes in postmenopausal breast cancer patients", by I.!Cohen -: Ann Oncol 2005; 16: 1399
Paridaens, R
Morales, L
Neven, P
Timmerman, D
[J]. ANNALS OF ONCOLOGY, 2005, 16 (08) : 1402 - 1403
[3] Reply to "Weekly paclitaxel as first-line chemotherapy in elderly advanced breast cancer patients:: a phase II study of the Gruppo Italiano di Oncologia Geriatrica (GIOGer)" by L.!Del Mastro et al. (Ann Oncol 2005; 16: 253-258)
Smorenburg, CH
ten Tije, AJ
[J]. ANNALS OF ONCOLOGY, 2005, 16 (12)